Ad hoc release: PAION announces that NMPA accepts submission of New Drug Application for remimazolam by Chinese licensee Yichang Humanwell
PAION announces that NMPA accepts submission of New Drug Application for remimazolam by Chinese licensee Yichang Humanwell
PDF
112 KB